Pimagedine
Alternative Names: ALT 11; Aminoguanidine hydrochlorideLatest Information Update: 24 Oct 2021
At a glance
- Originator Nonindustrial source; Rockefeller University
- Developer Alteon; Gamida; Nonindustrial source
- Class Guanidines; Hydrazines; Small molecules
- Mechanism of Action Advanced glycosylation end product inhibitors; Nitric oxide synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis; Coronary disorders; Dermatitis; Diabetic complications; Diabetic nephropathies; Stroke; Transplant rejection
Most Recent Events
- 22 Dec 2003 Discontinued - Preclinical for Coronary disorders in USA (PO)
- 22 Dec 2003 Discontinued - Preclinical for Stroke (IV)
- 22 Dec 2003 Discontinued - Preclinical for Transplant rejection in USA (unspecified route)